Processing...
Processing...
Inmagic
®
Presto
Version 5.5 Build 151
Inmagic
®
Presto
Copyright © 2005-2021 by Lucidea Technologies Corp., Richmond BC Canada. All rights reserved.
Inmagic® and the Inmagic logo are registered trademarks of Lucidea Technologies Corp.
Unauthorized duplication or distribution is prohibited.
Other brand and product names are trademarks or registered trademarks of their respective holders. Use of any other product name does not imply endorsement of that product by Inmagic.
Third-party Licenses
Processing...
Processing...
Title
Methylphenidate and Autism
Author
Research Autism
Summary
This online article describes and evaluates the use of methylphenidate, often sold under the brand name of Ritalin, which is a medication commonly used as a treatment for attention deficit hyperactivity disorder (ADHD).
The article concludes that there is strong evidence suggesting that methylphenidate may be a useful treatment for hyperactivity, impulsivity, and inattention in children on the autism spectrum. However, the article notes that there may be significant side effects, and it suggests that the medication should only be used under specialist supervision as part of a comprehensive treatment program for ADHD (which co-occur alongside autism) where other measures have been ineffective.
Research Autism was a charity funding research in autism interventions. Research Autism’s information services have been absorbed by the National Autistic Society (NAS). Founded in 1962, the NAS “provide[s] information, support and pioneering services, and campaign[s] for a better world for autistic people. [Website]
Language
English
Subjects
Diagnosis & Assessment
Publisher
Research Autism
DateModified
9/22/2022 3:23 PM EDT